CAPTRUST Financial Advisors
ADPT icon

CAPTRUST Financial Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$503K Buy
23,459
+2,559
+12% +$39.2K ﹤0.01% 2178
2026
Q1 		$290K Buy
20,900
+665
+3% +$10.6K ﹤0.01% 2412
2025
Q4 		$329K Buy
20,235
+305
+2% +$4.98K ﹤0.01% 2178
2025
Q3 		$298K Buy
19,930
+4,168
+26% +$50.8K ﹤0.01% 2170
2025
Q2 		$184K Buy
15,762
+1,119
+8% +$10.2K ﹤0.01% 2320
2025
Q1 		$109K Buy
14,643
+1,059
+8% +$8.14K ﹤0.01% 2229
2024
Q4 		$81.4K Buy
13,584
+654
+5% +$3.61K ﹤0.01% 2216
2024
Q3 		$66.2K Buy
12,930
+1,617
+14% +$7.04K ﹤0.01% 2224
2024
Q2 		$41K Buy
11,313
+1,019
+10% +$3.23K ﹤0.01% 2159
2024
Q1 		$33K Sell
10,294
-1,700
-14% -$6.58K ﹤0.01% 2101
2023
Q4 		$58.8K Buy
11,994
+539
+5% +$2.46K ﹤0.01% 2575
2023
Q3 		$62.4K Sell
11,455
-740
-6% -$4.89K ﹤0.01% 2466
2023
Q2 		$81.8K Buy
12,195
+69
+0.6% +$513 ﹤0.01% 2399
2023
Q1 		$107K Buy
+12,126
New +$107K ﹤0.01% 2151
2022
Q4 		– Sell
-12,317
Closed -$88K – 2055
2022
Q3 		$88K Buy
12,317
+11,162
+966% +$105K ﹤0.01% 1948
2022
Q2 		$9K Sell
1,155
-373
-24% -$3.28K ﹤0.01% 3782
2022
Q1 		$21K Buy
1,528
+758
+98% +$11.9K ﹤0.01% 3343
2021
Q4 		$22K Buy
770
+180
+31% +$5.52K ﹤0.01% 3219
2021
Q3 		$20K Hold
590
– – ﹤0.01% 3158
2021
Q2 		$24K Sell
590
-870
-60% -$33.8K ﹤0.01% 2975
2021
Q1 		$59K Buy
1,460
+270
+23% +$14.6K ﹤0.01% 2320
2020
Q4 		$70K Sell
1,190
-6
-0.5% -$309 ﹤0.01% 1679
2020
Q3 		$59K Buy
+1,196
New +$50.3K ﹤0.01% 1572

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CAPTRUST Financial Advisors's ADPT Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Adaptive Biotechnologies (ADPT) stake by 12% in Q2 2026, buying an estimated $39.2K and bringing the position to 23,459 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

CAPTRUST Financial Advisors first reported a position in ADPT in Q3 2020 and has held it in 23 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • CAPTRUST Financial Advisors held 23,459 shares of Adaptive Biotechnologies worth $503K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 2,559 Adaptive Biotechnologies shares in Q2 2026, an estimated $39.2K.
  • Adaptive Biotechnologies made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2178 holding.
  • CAPTRUST Financial Advisors first reported a position in Adaptive Biotechnologies in Q3 2020 and has held it in 23 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.